TGFB2 signaling is relevant to pathogenesis of many cancers, including gliomas and pancreatic cancers (Dietrich, Dutoit, Tran Thang, & Walker, 2010; Hau, Jachimczak, Schlaier, & Bogdahn, 2011). This evidence concerns the gene TGFB2 and pancreatic neoplasm.